ROBO1 and breast carcinoma: In an earlier study, we demonstrated that there were no inactivating somatic mutations in ROBO1 in lung and breast cancers, but a CpG island in the 5′ region of ROBO1 was hypermethylated in breast and kidney tumours (Dallol et al, 2002b).